Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China. Qi Y, Cao X, Gao XQ, Cheng X, et al. Ren Fail 2026;48:2612448.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qi Y, Cao X, Gao XQ, Cheng X, et al. Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China. Ren Fail 2026;48:2612448.
PMID: 41582001